Gilead Sciences, Inc. (GILD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeeking Alpha • 09/04/25
Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIVBusiness Wire • 09/04/25
Gilead Sciences, Inc. (GILD) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeeking Alpha • 09/03/25
Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation StrategyBusiness Wire • 09/03/25
GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EUZacks Investment Research • 08/26/25
Gilead Sciences' 99.9% Effective HIV Treatment Notches Another WinInvestors Business Daily • 08/26/25
European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV PreventionBusiness Wire • 08/26/25
Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV DrugInvestors Business Daily • 08/21/25
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its PlansBenzinga • 08/21/25
Exclusive: CVS holds off adding Gilead's new HIV prevention shot to drug coverage listsReuters • 08/20/25
Gilead Sciences shares soar; analysts lift targets on HIV strength and Yeztugo outlookInvezz • 08/08/25
These Stocks Are Moving Most Today: Trade Desk, Expedia, Pinterest, Twilio, Gilead SciencesBarrons • 08/08/25